Latest news from Moleculera Labs, Inc. on Newswise en-us Copyright 2024 Newswise 115 31 / /images/newswise-logo-rss.gif /articles/biomarker-based-test-delivers-precision-medicine-to-children-with-complex-neuropsychiatric-illnesses/?sc=rsin /articles/biomarker-based-test-delivers-precision-medicine-to-children-with-complex-neuropsychiatric-illnesses/?sc=rsin Fri, 09 Sep 2016 08:05:31 EST Researchers from the University of Oklahoma Health Sciences Center, in collaboration with the National Institute of Mental Health, have developed the first-of-its-kind biomarker test to help identify autoimmune-induced neuropsychiatric disorders. Moleculera Labs, Inc.